Cargando…
Lipidomics of the brain, retina, and biofluids: from the biological landscape to potential clinical application in schizophrenia
Schizophrenia is a serious neuropsychiatric disorder, yet a clear pathophysiology has not been identified. To date, neither the objective biomarkers for diagnosis nor specific medications for the treatment of schizophrenia are clinically satisfactory. It is well accepted that lipids are essential to...
Autores principales: | Zhuo, Chuanjun, Hou, Weihong, Tian, Hongjun, Wang, Lina, Li, Ranli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653030/ https://www.ncbi.nlm.nih.gov/pubmed/33168817 http://dx.doi.org/10.1038/s41398-020-01080-1 |
Ejemplares similares
-
Biofluid lipidome: a source for potential diagnostic biomarkers
por: Ghosh, Arkasubhra, et al.
Publicado: (2017) -
Brain imaging features in schizophrenia with co‐occurring auditory verbal hallucinations and depressive symptoms—Implication for novel therapeutic strategies to alleviate the reciprocal deterioration
por: Zhuo, Chuanjun, et al.
Publicado: (2020) -
Exploration of the cortical pathophysiology underlying visual disturbances in schizophrenia comorbid with depressive disorder—An evidence from mouse model
por: Liu, Jian, et al.
Publicado: (2021) -
Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target
por: Zhuo, Chuanjun, et al.
Publicado: (2022) -
Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale
por: Lin, Xiao, et al.
Publicado: (2023)